Elisa For The Detention Of Er And Pr In Breast Cancer

Cancer of the breast without ER, PR, HER2 expression, 48 cases (1.5mm), set 1HumanBreastBreastMalignant

BRC964 1
EUR 519

Breast Elisa Laboratories manufactures the elisa for the detention of er and pr in breast cancer reagents distributed by Genprice. The Elisa For The Detention Of Er And Pr In Breast Cancer reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact breast elisa. Other Elisa products are available in stock. Specificity: Elisa Category: For Group: The Detention

Advanced stage breast cancer and normal breast tissue array

each
EUR 306
Description: Advanced stage breast cancer and normal breast tissue array, including pathology grade, TNM and clinical stage (AJCC 8.0), ER\PR\HER-2\Ki-67 marker, 119 cases/119 cores, (1.5mm)

Breast Tumor Tissue Array - Duplicated 36 cases covering all the common types of breast cancer and 12 cases of normal an

5 slides
EUR 1657.2
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Breast Tumor Tissue Array - Duplicated 36 cases covering all the common types of breast cancer and 12 cases of normal an

5 slides
EUR 1657.2
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Cancer of the breast, 75 cases (1.1mm), set 1HumanBreastBreastMalignant

1
EUR 289

Cancer of the breast, 75 cases (1.1mm), set 10HumanBreastBreastMalignant

1
EUR 289

Cancer of the breast, 75 cases (1.1mm), set 11HumanBreastBreastMalignant

1
EUR 289

Cancer of the breast, 75 cases (1.1mm), set 12HumanBreastBreastMalignant

1
EUR 289

The Detention information

Cancer of the breast, 75 cases (1.1mm), set 13HumanBreastBreastMalignant

BRC15013 1.1mm
EUR 289

ELISA Kit for Breast Cancer Susceptibility Protein 2 (BRCA2)

SEB364Hu 96Т
EUR 665

ELISA Kit for Breast Cancer Susceptibility Protein 2 (BRCA2)

SEB364Mu 96Т
EUR 684

ELISA Kit for Breast Cancer Susceptibility Protein 1 (BRCA1)

SEB376Hu 96Т
EUR 665

ELISA Kit for Human Breast cancer metastasis-suppressor 1

E9631h 96T
EUR 441.6

BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) (PE)

MBS6156710-01mL 0.1(mL
EUR 875

BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) (PE)

MBS6156710-5x01mL 5x0.1mL
EUR 3800

BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) (AP)

MBS6130195-01mL 0.1(mL
EUR 875

BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) (AP)

MBS6130195-5x01mL 5x0.1mL
EUR 3800

BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) APC

MBS6135498-01mL 0.1(mL
EUR 875

BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) APC

MBS6135498-5x01mL 5x0.1mL
EUR 3800

BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) (FITC)

MBS6146104-01mL 0.1(mL
EUR 875

BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) (FITC)

MBS6146104-5x01mL 5x0.1mL
EUR 3800

BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) (HRP)

MBS6151407-01mL 0.1(mL
EUR 875

BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) (HRP)

MBS6151407-5x01mL 5x0.1mL
EUR 3800

BCAS1, CT (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1)

MBS646867-005mg 0.05mg
EUR 875

BCAS1, CT (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1)

MBS646867-5x005mg 5x0.05mg
EUR 3780